Dyadic International
在场
Dyadic International 是一家在股票代码 DYAI (US) 下上市的公司。
高管
查看带有其 10 名主要高管的组织结构图
Dyadic International 搜索最多的简介
- Mark Emalfarb, Chief Executive Officer and President
- Patrick Lucy, Chairman of the Board
- Michael Tarnok, Director
高管在Dyadic International变化
- Patrick Lucy 曾任 Director, 现升职为 Chairman of the Board (新闻发布的2024三月29号).
创建提醒
跟踪 Dyadic International 的高管变动
生物技术
Dyadic International 拥有 2,328 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Integral Diagnostics and Capitol Health Limited have announced they will merge (公布2024十一月26号)..
- Inbrain Neuroelectronics 刚刚宣布为 50 筹款数百万美元。 (公布2024十一月23号).
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
生物技术 行业的其他推荐联系人
消息
Dyadic International 的最新新闻稿
- RSS Feed of Press Releases for DYAIDyadic to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018Dyadic Announces Analyst Coverage Initiated by Zacks Small-Cap ResearchDyadic International to Present Thursday October 4, 2018 at 2:30
- Press Releases | Dyadic International, Inc :Dyadic International, Inc
- Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Platform to Manufacture Biologics | Dyadic International, Inc :Dyadic International, Inc
通过电子邮件
